FDA Approves MiniMed Paradigm Real-Time Insulin Pump
According to the Associated Press, the FDA has just approved the MiniMed Paradigm real-time insulin pump. This is the closest thing we have so far to an artificial pancreas, and because it will allow nearly continuous blood-glucose readings combined with pump technology, this will allow better blood glucose control. It should greatly help in reducing or delaying complications.
The Paradigm pump has a glucose sensor in the form of a tiny electrode that is inserted under the patient’s skin. Up to 288 readings a day are displayed on the pump, which means approximately one reading every five minutes. Medtronic called it a major step toward a closed-loop insulin delivery system, which I have explained in previous blogs. I believe this is the product that last week’s guest blogger, Wil, was using and writing about.
The only bad news is that the government agency that sets Medicare reimbursement policy is not likely to set reimbursement codes for it anytime soon. But we’ll keep our fingers crossed.
You may also enjoy reading these blogs:
Sports Heroes For Type I Kids
Thoughts On Summer Camps
Published On: April 17, 2006